hydroxyisohexyl 3-cyclohexene carboxaldehyde hamilelikte güvenli mi?

Hamilelikte hydroxyisohexyl 3-cyclohexene carboxaldehyde yerine kullanılabilecek güvenli alternatifler | VeriMom

Related ingredients

Frequently asked questions

hydroxyisohexyl 3-cyclohexene carboxaldehyde hamilelikte güvenli mi?

No harmonised CLP reproductive classification (H360/H361) for hydroxyisohexyl 3-cyclohexene carboxaldehyde (HICC / Lyral) was identified in the authoritative ECHA/C&L materials; the regulatory and expert literature and safety reviews focus on skin sensitisation rather than reproductive toxicity. Systemic exposure from normal cosmetic topical use is low but measurable, so exposure during pregnancy is scored as low (e=1). Sources: SCCS opinion on HICC (sensitisation focus) and ECHA notices/public consultation (no confirmed harmonised repro classification). (https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_q_022.pdf; https://echa.europa.eu/all-news/-/journal_content/56d34d61-2a1f-4f23-a3d6-0f4f5a5a0b9a).

hydroxyisohexyl 3-cyclohexene carboxaldehyde emzirirken güvenli mi?

There is no credible evidence in authoritative safety reviews or peer‑reviewed studies that HICC is a reproductive or lactation hazard or that it concentrates in milk; therefore hazard (h) and mechanism (m) are scored 0. Because topical use can produce low but measurable systemic absorption in adults, breastfeeding exposure is scored low (e=1). Sources: RIFM/Cosmetic safety reviews and PubChem summary; no studies showing transfer to milk or developmental effects were located. (https://pubmed.ncbi.nlm.nih.gov/35605712/; https://pubchem.ncbi.nlm.nih.gov/compound/Hydroxyisohexyl-3-cyclohexene-carboxaldehyde).

hydroxyisohexyl 3-cyclohexene carboxaldehyde bebek cildi için güvenli mi?

No infant‑specific data showing reproductive or developmental toxicity; primary, high‑priority sources (SCCS, RIFM reviews, peer‑reviewed literature) identify HICC chiefly as a contact allergen (skin sensitiser), not a developmental toxicant. Because infant skin (0–3 yr) has higher absorption per body weight and an immature barrier, exposure score is increased by +1 relative to adults (adult e=1 → baby e=2). Note: this scoring does not change the hazard (h) or mechanism (m) in the absence of infant‑specific evidence. (SCCS opinion and multiple patch‑test / contact dermatitis studies). (https://ec.europa.eu/health/scientific_committees/consumer_safety/docs/sccs_q_022.pdf; https://pubmed.ncbi.nlm.nih.gov/27767215/; https://pubmed.ncbi.nlm.nih.gov/23869726/).

VeriMom hydroxyisohexyl 3-cyclohexene carboxaldehyde nasıl puanlıyor?

VeriMom hydroxyisohexyl 3-cyclohexene carboxaldehyde'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 53/100 (orta risk) olarak puanlar.

Hamilelikte hydroxyisohexyl 3-cyclohexene carboxaldehyde yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.